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Abstract  
The administration of the methanol leaf extract of Alchornea laxiflora (Benth) Pax and Hoffman regulates blood 
sugar levels in alloxan-induced diabetic rats. A. laxiflora therapy also caused significant reductions in hitherto 
raised levels of plasma cholesterol, urea and creatinine and reversed the decreases in concentration of plasma 
total protein and albumin following alloxan injection (p<0.05). The significant increases in activity (p<0.05) 
elicited in plasma liver enzymes studied: aspartate aminotransferase, alanine aminotransferase and alkaline 
phosphatase, in the diabetic rats were gradually restored to normal values (p<0.05). No significant changes 
(p>0.05) were observed in the normal rats administered with the extract. Thus A. laxiflora is an 
antihyperglycaemic agent and not hypoglycaemic and appears to correct the metabolic derangements indicative 
of diabetes mellitus.  
Keywords: Alchornea laxiflora (Benth) Pax and Hoffman, antihyperglycaemic, diabetic rats, methanol, leaf, 
extract. 
 
1. INTRODUCTION  
The use of medicinal plants as antidiabetic agents is common place in developing countries. In view of this, the 
WHO expert committee on diabetes mellitus (WHO, 1980) recommended that it is important to investigate the 
effect of agents of plant origin used in traditional medicine.  
Diabetes mellitus refers to the group of diseases that leads to high blood glucose levels due to defects in 
either insulin secretion or insulin action (Rother, 2007). Most cases of diabetes mellitus fall into one of two 
broad categories: type 1 and type 2. The principal treatment of type 1 diabetes even in its earliest stages is the 
delivery of artificial insulin via injection. Type 2 diabetes is usually first treated by increasing physical activity, 
decreasing carbohydrate intake and losing weight, and in later stages, if necessary, treatment with oral 
medication to improve insulin production (e.g. sulphonylureas), to regulate inappropriate release of glucose by 
the liver and attenuate insulin resistance to some extent (e.g. metformin) and to substantially attenuate insulin 
resistance e.g. thiazolidinediones) (UK Prospective Diabetes Study Group, 1998). Long term complications 
include retinal damage, nerve damage, microvascular disease, cardiovascular disease, liver damage, renal failure 
etc if the disease is not adequately controlled.  
Diabetes epidemic is spreading in the developing world and the number of people with diabetes will 
increase by 150% by 2030 with an increasing proportion of affected people in younger age groups (WHO, 2003; 
Ingrid and Matthias, 2006). In spite of the variety of drugs used for diabetic treatment, a perfect glycemic control 
is rarely achieved, thus making it imperative for new alternatives to be investigated.  
Alchornea laxiflora (Benth) Pax and Hoffman (Family: Euphorbiaceae), commonly called “pepe” in 
Southwest Nigeria, is a tree which grows to about 6 m. It is also found in the Cameroon and it is widespread in 
the Central and Southern tropical Africa. The leaves play important role in the preservation of kolanuts widely 
eaten in Nigeria. The stems and branches are also used in Nigeria as chewing stick. Deconctions of the leaves are 
used in the treatment and management of inflammatory and infectious diseases (Adewole, 1993; Ogundipe et al., 
2001). The methanolic extract of Alchornea laxiflora (the leaves and root) possess antioxidant activities 
(Farombi et al., 2003).  
This study reports the effects of the methanolic leaf extract of Alchornea laxiflora (Benth) Pax and 
Hoffman on biochemical indices such as glycaemic control, lipid profile, liver and renal dysfunction markers in 
alloxan-induced diabetic rats.  
 
2. MATERIALS AND METHODS 
2.1 Chemicals/Reagents   
Alloxan monohydrate was purchased from Sigma Chemical Company, MO, USA.  
Assay kits for biochemical analysis were purchased from Randox Laboratory Ltd, UK.  
All other reagents were of analytical grade.  
 
2.2 Animals  
24 albino rats of wistar strain (males and females) weighing between 150 – 250 g bred in the animal house of 
Pharmacology Department, University of Benin, Benin City were used. Animals were housed in clean metal 
cages at a temperature of 25 ± 2 0C with 12 hours light/dark cycles. They were acclimatized for one week and 
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received a pellet diet (Bendel Feed Mill, Ewu, Edo State, Nigeria) and water ad libitum.  
Animals were handled in accordance with internationally accepted principles for laboratory animal use and 
care (NIH Publication 85 – 193, revised 1985).  
 
2.3 Induction of Diabetes  
Animals received a freshly prepared solution of 100 mg of alloxan monohydrate (dissolved in distilled water) per 
kg body weight, intraperitonially for two consecutive days. Two days was allowed for stabilization of the 
injected alloxan, and rats showing mild diabetes with hyperglycaemia (blood glucose concentrations of 140 – 
150 mg/dl) were used for the experiment. Rats were initially fasted overnight (14 h) and blood drained from tail 
vein of conscious rats for base line values of fasting blood glucose (FBG) and other biochemical parameters. 
Thereafter, rats were fasted on alternate days.  
 
2.4 Experimental Design  
The rats were randomly divided into 4 groups with 6 animals each. 500 mg/kg body weight of Alchornea 
laxiflora (Benth) Pax and Hoffman methanol leaf extract was administered to Groups 2 and 4 rats orally by 
gavage twice daily.  
Group 1: Normal rats received water (Normal control). 
Group 2: Normal rats received A. laxiflora (500 mg/kg body weight) in solution. 
Group 3: Diabetic rats received water (Diabetic control). 
Group 4: Diabetic rats received A. laxiflora (500 mg/kg body weight) in solution. 
 
2.5 Plant Material and Extraction  
Alchornea laxiflora plant was collected from a cocoa plantation at Alade, Idanre town, Ondo State, Nigeria. The 
plant was identified and authenticated at the Plant Biology and Biotechnology Department Herbarium, 
University of Benin, Benin City, Nigeria. The leaves were subsequently sun-dried for a week, after which they 
were blended into powder.  
100 g of the powdered sample was soaked in 500 ml of methanol for 60 h. The resultant mixture was sieved 
and the filtrate concentrated by evaporation in a water bath (Gallenkamp, UK) at 80 0C giving a semi-solid 
extract. 20 g of the extract was reconstituted to 100 ml with distilled water and refrigerated at 4 0C until required.  
 
2.6 Blood Collection  
Blood samples were withdrawn from conscious rats by tail vein puncture 3 days after alloxan induction, Day 20 
(pre-treatment) and afterwards on days 22, 24 and 26 (post-treatment). Blood samples were collected into vials 
containing sodium fluoride and EDTA for the determination of blood glucose and other blood parameters 
respectively. The samples collected were immediately placed on ice and centrifuged (Gallenkamp, UK) at 3500 
r.p.m. for 10 min to obtain the plasma.  
 
2.7 Biochemical Analysis  
Assay kits from Randox Laboratory Limited, UK were used for estimation of concentrations of glucose, 
cholesterol, total protein, albumin, urea and creatinine. 
Serum glucose concentration was estimated using enzymatic colorimetric kits (Randox Laboratory, UK) in 
which the glucose oxidase/peroxidase/4-aminophenazone method of Trinder (1969) was adopted. Plasma 
cholesterol was estimated by the method described in the Randox cholesterol kit where the indicator 
quinoneimine is formed from hydrogen peroxide and 4-amino antipyrene in the presence of phenol and 
peroxidase. Absorbance of the sample and standard were read against the reagent blank within 60 min at 546 nm. 
The protein concentration in the plasma was determined using the biuret method for detecting the presence of 
peptide bonds as described in the Randox Total Protein kit (Tietz, 1995). The albumin concentration in the 
plasma was determined as described by Doumas et al. (1971), based on the quantitative binding of the albumin 
to the indicator bromocresol green (BCG). The albumin-BCG complex absorbs maximally at 578 nm. Plasma 
urea concentration was determined by photometrically measuring the ammonia liberated by the urea in plasma in 
the presence of urease (Berthlot’s reaction). Absorbance was read at 546 nm (Weatherburn, 1967). Creatinine 
concentration in the plasma was determined as described in the Randox creatinine kit.  
 
2.8 Liver Enzyme Assays  
The activities in plasma of alanine aminotransferase (ALT), aspartate aminotransferase (ASP) and alkaline 
phosphatase (ALP) were assayed by the methods described in the Randox kits and values expressed in IU/L. 
 
2.9 Statistical Analysis  
Data were analyzed using Analysis of Variance (ANOVA) by employing the method of Steel and Torrie (1960). 
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Significant difference between the treatment means was determined at 95% confidence level using Dancan’s 
Multiple Range Test (Duncan, 1955).  
 
3. RESULTS  
The results of blood glucose concentration in experimental animals are presented in Table 1. Alloxan-induction 
cased a significant increase (p<0.05) in blood glucose concentrations (Groups 3 and 4) when compared with 
normal rats (Group 1). Administration of methanol leaf extract of A. laxiflora to normal rats (Group 2) did not 
cause any significant changes (p>0.05). However, administration of the extract resulted in significant decreases 
(p<0.05) in blood glucose concentration of the diabetic treated rats (Group 4) compared to diabetic control rats 
(Group 3).  
Table 1: Effect of A. laxiflora extract on fasting plasma glucose concentration of normal and diabetic rats (mg/dl) 
Group Basal Treatment Began Post-Treatment 
Day 15 Day 20 Day 22 Day 24 Day 26 
1 56.80 ± 10.01a 57.68 ± 5.11a 56.95 ± 3.28a 58.00 ± 5.01a 57.98 ± 6.77a 
2 63.60 ± 6.18a 61.40 ± 6.63a 62.62 ± 6.53a 63.84 ± 1.92a 62.76 ± 1.12a 
 Pre-Alloxan   Post-Alloxan   
3 58.15 ± 10.57a 144.85 ± 11.18b 158.42 ± 3.13b 165.48 ± 5.84b 177.17 ± 9.40b 
4 57.27 ± 5.25a 146.12 ± 12.90b 102.21 ± 15.66c 92.19 ± 2.09c 87.66 ± 5.93c 
Data are means ± SEM of 6 determinations. Values in the same column carrying different superscripts are 
significantly different (P≤0.05). 
Table 2 shows alloxan induction caused significant increases (p<0.05) in plasma cholesterol concentration 
of rats in Groups 3 and 4 while significant (p<0.05) decreases were observed in the diabetic rats administered 
with the extract compared to diabetic untreated rats (Group 3). No such changes (p>0.05) occurred with the 
normal treated rats (Group 2).  
Table 2: Effect of A. laxiflora extract on plasma cholesterol concentration of normal and diabetic rats (mg/dl) 
Group Basal Treatment Began  Post-Treatment 
Day 15 Day 20 Day 22 Day 24 Day 26 
1 64.47 ± 16.78a 66.84 ± 16.53a 68.28 ± 3.79a 64.50 ± 0.51a 65.55 ± 15.05a 
2 63.19 ± 6.53a 66.24 ± 5.09a 65.00 ± 10.26a 65.90 ± 2.80a 65.50 ± 2.70a 
 Pre-Alloxan   Post-Alloxan   
3 64.84 ± 7.53a 79.28 ± 6.08b 86.42 ± 4.51b 97.13 ± 4.36b 105.98 ± 5.00b 
4 63.71 ± 5.77a 76.80 ± 3.45b 71.96 ± 7.09a 67.87 ± 8.50a 63.25 ± 3.72a 
Data are means ± SEM of 6 determinations. Values in the same column carrying different superscripts are 
significantly different (P≤0.05). 
Alloxan induction caused decreases in plasma total protein concentration in diabetic rats (Groups 3 and 4) 
but these were not statistically different (p>0.05) on Day 20 (Table 3). However, the diabetic control rats (Group 
3) continued to have decreased protein concentrations which were significant (p<0.05) compared to other groups. 
Though administration of A. laxiflora methanol leaf extract did not cause any significant changes (p>0.05) to the 
normal treated rats (Group 2), it restored protein levels back to normal in treated diabetic rats (Group 4).  
Table 3: Effect of A. laxiflora extract on plasma total protein concentration of normal and diabetic rats (g/dl) 
Group Basal Treatment Began  Post-Treatment 
Day 15 Day 20 Day 22 Day 24 Day 26 
1 5.76 ± 0.14a 4.25 ± 0.84a 6.99 ± 0.18a 5.45 ± 0.10a 5.62 ± 0.70a 
2 5.45 ± 0.18a 5.04 ± 0.28a 5.53 ± 0.76a 5.81 ± 0.08a 5.95 ± 0.48a 
 Pre-Alloxan   Post-Alloxan   
3 5.35 ± 0.39a 4.35 ± 0.54a 3.68 ± 0.12b 2.83 ± 0.15b 2.24 ± 0.43b 
4 5.78 ± 0.14a 3.83 ± 0.47a 6.05 ± 0.68a 4.97 ± 0.36a 5.22 ± 0.36a 
Data are means ± SEM of 6 determinations. Values in the same column carrying different superscripts are 
significantly different (P≤0.05). 
Results of the concentrations of albumin in experimental rats are presented in Table 4. Alloxan induction 
caused significant decreases (p<0.05) in the diabetic rats compared to normal rats. While albumin levels in the 
diabetic control rats continue to decrease (p<0.05), administration of the extract brought the plasma albumin 
levels in Group 4 rats back to normal. Administration of the extract to normal rats (Group 2) did not cause any 
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Table 4: Effect of A. laxiflora extract on plasma albumin concentration of normal and diabetic rats (g/dl) 
Group Basal Treatment Began  Post-Treatment 
Day 15 Day 20 Day 22 Day 24 Day 26 
1 4.50 ± 0.04a 4.28 ± 0.25a 4.50 ± 0.10a 4.93 ± 0.47a 4.74 ± 0.58a 
2 4.71 ± 0.10a 4.26 ± 0.15a 4.43 ± 0.13a 4.70 ± 0.13a 4.01 ± 0.25a 
 Pre-Alloxan   Post-Alloxan   
3 4.29 ± 0.20a 4.07 ± 0.10bc 3.77 ± 0.27b 3.55 ± 0.32b 2.77 ± 0.45b 
4 4.62 ± 0.11a 3.52 ± 0.15c 3.55 ± 0.25b 3.98 ± 0.54ab 4.33 ± 0.13a 
Data are means ± SEM of 6 determinations. Values in the same column carrying different superscripts are 
significantly different (P≤0.05). 
Alloxan induction caused significant increases (p<0.05) in urea concentration in the rats in Groups 3 and 4, 
compared to the normal rats (Group 1) (Table 5). While administration of the extract caused a lowering (p<0.05) 
of urea concentration in the diabetic treated rats, changes observed in normal rats treated with the extract were 
non-significant (p>0.05). 
Table 5: Effect of A. laxiflora extract on plasma urea concentration of normal and diabetic rats (mg/dl) 
Group Basal Treatment Began  Post-Treatment 
Day 15 Day 20 Day 22 Day 24 Day 26 
1 27.29 ± 1.70a 28.76 ± 5.99a 29.64 ± 3.26a 29.08 ± 3.69a 28.64 ± 4.08a 
2 26.58 ± 6.00a 29.23 ± 5.76a 27.42 ± 5.73a 30.24 ± 2.35a 28.29 ± 0.90a 
 Pre-Alloxan   Post-Alloxan   
3 27.75 ± 1.50a 60.83 ± 11.75b 66.71 ± 2.37b 67.75 ± 4.38b 67.22 ± 3.00b 
4 28.29 ± 1.41a 60.63 ± 13.22b 52.12 ± 15.57c 45.08 ± 9.01c 33.45 ± 5.38a 
Data are means ± SEM of 6 determinations. Values in the same column carrying different superscripts are 
significantly different (P≤0.05). 
Table 6 shows plasma concentrations of creatinine in experimental rats. Following the induction of diabetes, 
plasma creatinine levels were significantly (p<0.05) raised in Groups 3 and 4 rats. Administration of the extract 
elicited a significant (p<0.05) lowering of hitherto raised levels of creatinine. The extract had no significant 
(p>0.05) effect on normal rats (Group 2).  
Table 6: Effect of A. laxiflora extract on plasma creatinine concentration of normal and diabetic rats (mg/dl) 
Group Basal Treatment Began  Post-Treatment 
Day 15 Day 20 Day 22 Day 24 Day 26 
1 0.96 ± 0.06a 1.01 ± 0.21a 1.04 ± 0.11a 1.02 ± 0.13a 1.00 ± 0.14a 
2 0.93 ± 0.21a 1.02 ± 0.20a 0.96 ± 0.20a 1.06 ± 0.08a 0.99 ± 0.03a 
 Pre-Alloxan   Post-Alloxan   
3 0.97 ± 0.05a 2.13 ± 0.41b 2.33 ± 0.08b 2.37 ± 0.15b 2.35 ± 0.38b 
4 0.99 ± 0.05a 2.12 ± 0.46b 1.47 ± 0.54a 1.23 ± 0.32a 1.00 ± 0.19a 
Data are means ± SEM of 6 determinations. Values in the same column carrying different superscripts are 
significantly different (P≤0.05). 
Results of the liver enzyme assays in plasma are shown in Tables 7, 8 and 9. Alloxan induction caused a 
statistically significant (p<0.05) increase in plasma aspartate aminotransferase (ASP) activities in Group 3 and 4 
rats (Table 7). While the activities continued to increase in the diabetic control rats (Group 3), administration of 
the extract caused a lowering of the activities of ASP in plasma of Group 4 rats. Administration of the extract to 
normal rats (Group 2) did not cause any statistically significant (p>0.05) changes.  
Alloxan induction caused significant increases (p<0.05) in alanine aminotransferase activities in plasma of 
the diabetic rats (Group 3 and 4) (Table 8). While the activities of ALT continued to increase in the diabetic 
control rats, there was a gradual lowering of the ALT activities in the plasma of the diabetic rats administered 
with the extract (p<0.05). No significant changes were observed in the normal rats treated with the extract 
(Group 2) compared to the untreated normal rats (Group 1).  
As observed in Table 9, alloxan-induced rats had increased alkaline phosphatase (ALP) activities in plasma. 
Administration of the methanol leaf extract of A. laxiflora caused a statistically significant lowering (p<0.05) of 
the ALP activities. The extract did not elicit any significant differences (p>0.05) in plasma ALP activities on 
administration to normal rats (Group 2).  
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Table 7: Effect of A. laxiflora extract on plasma activities of aspartate aminotransferase (ASP) in normal and 
diabetic rats (IU/L) 
Group Basal Treatment Began  Post-Treatment 
Day 15 Day 20 Day 22 Day 24 Day 26 
1 23.40 ± 2.38a 23.80 ± 7.66a 23.50 ± 7.38a 23.90 ± 7.23a 23.60 ± 2.80a 
2 23.00 ± 3.33a 23.80 ± 2.13a 23.20 ± 1.91a 26.80 ± 4.05a 24.70 ± 3.75a 
 Pre-Alloxan   Post-Alloxan   
3 23.83 ± 2.15a 35.17 ± 6.61a 46.83 ± 3.32b 55.67 ± 2.39b 60.33 ± 3.02b 
4 23.50 ± 2.32a 40.33 ± 7.41b 39.17 ± 6.00c 35.73 ± 3.36a 31.50 ± 2.84a 
Data are means ± SEM of 6 determinations. Values in the same column carrying different superscripts are 
significantly different (P≤0.05). 
 
Table 8: Effect of A. laxiflora extract on plasma activities of alanine aminotransferase (ALT) in normal and 
diabetic rats (IU/L) 
Group Basal Treatment Began  Post-Treatment 
Day 15 Day 20 Day 22 Day 24 Day 26 
1 24.60 ± 2.04a 22.80 ± 1.46a 26.20 ± 3.79a 24.20 ± 4.29a 24.60 ± 4.76a 
2 24.60 ± 6.55a 29.80 ± 4.07a 26.40 ± 3.52a 24.80 ± 0.73a 24.70 ± 3.36a 
 Pre-Alloxan   Post-Alloxan   
3 24.50 ± 7.91a 43.83 ± 2.40b 49.17 ± 1.70bc 49.83 ± 3.07bc 52.83 ± 4.57b 
4 24.17 ± 10.98a 36.33 ± 7.97b 37.17 ± 7.18c 35.33 ± 2.82c 32.33 ± 7.97a 
Data are means ± SEM of 6 determinations. Values in the same column carrying different superscripts are 
significantly different (P≤0.05). 
 
Table 9: Effect of A. laxiflora extract on plasma activities of alkaline phosphatase (ALP) in normal and diabetic 
rats (IU/L) 
Group Basal Treatment Began  Post-Treatment 
Day 15 Day 20 Day 22 Day 24 Day 26 
1 23.58 ± 3.47a 25.79 ± 0.91a 26.28 ± 2.77a 25.30 ± 0.34a 26.51 ± 1.06a 
2 23.22 ± 0.92a 25.80 ± 0.63a 23.94 ± 1.35a 26.03 ± 1.66a 26.04 ± 0.87a 
 Pre-Alloxan   Post-Alloxan   
3 23.18 ± 2.14a 38.61 ± 1.15b 40.87 ± 2.03b 45.49 ± 1.14b 46.58 ± 3.81b 
4 23.39 ± 1.85a 37.20 ± 2.11b 35.22 ± 2.34c 29.31 ± 0.38a 28.83 ± 1.21a 
Data are means ± SEM of 6 determinations. Values in the same column carrying different superscripts are 
significantly different (P≤0.05). 
 
4. DISCUSSION  
Vegetable substances often in the form of powders or teas have long been used as popular remedies for diabetes 
mellitus. The present study investigated the effects of Alchornea laxiflora (Benth) Pax and Hoffman methanol 
leaf extract on some biochemical indices in albino rats with the aim of scientifically establishing its 
ethnomedicinal use as an antidiabetic agent. 
Alloxan induction of rats caused an increases in blood glucose from 57.27 ± 5.25 mg/dl to 146.12 ± 12.90 
mg/dl in Group 4 rats. Hyperglycaemia is an important factor in the development and progression of the 
complications of diabetes mellitus. Effective blood glucose control is the key for preventing or reversing diabetic 
complications (Marx, 2002). This study has clearly demonstrated the glucose lowering effect of A. laxiflora in 
the diabetic state. The significant reductions in glucose levels of diabetic rats administered the methanol extract 
of A. laxiflora may be due to the presence of antihyperglycaemic principles such as tannins saponins, alkaloids 
and glycosides reported to be present in the plant (Adegoke et al., 1968). The plant did not exhibit 
hypoglycaemic properties as no significant changes ensured when normal rats were treated with the methanol 
extract of the leaf. Other workers have also reported antihyperglycaemic properties in some medicinal plants 
(Nimenibo-Uadia and Osagie, 1999; Adeyemi et al., 2015). 
Cholesterol and other lipids are raised in the diabetic state. Elevation of plasma cholesterol has been well 
documented in diabetes (Chase and Glasgow, 1976). The gradual reduction in cholesterol level on administration 
of the extract to diabetic rats shows A. laxiflora has antihypercholesterolaemic effects. Some medicinal plants 
have been reported to lower high concentrations of lipids in diabetic rats (Sharma et al., 2003; Adeyemi et al., 
2015). However, its non-significant effect in normal rats suggests A. laxiflora cannot be employed in treating 
non-diabetes related lipid diseases.   
Both protein and albumin concentrations in the diabetic control rats continued to fall (decreases of 58.13% 
for protein and 35.43% for albumin by Day 26). Alloxan may have damaged the liver thus impairing protein 
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(including albumin) synthesis. Albumin is the most abundant serum protein representing 55 – 65% of the total 
protein. Hypoalbuminaemia is associated with impaired albumin synthesis in the liver, liver disease, malnutrition 
or malabsorption. In diabetes, there is a decreased synthesis of proteins and hence less albumin is synthesized by 
the liver because of the need of amino acids for gluconeogenesis (William, 1989). Protein metabolism is also 
affected in diabetes. There is increased catabolism of proteins and the less protein synthesis, leads to debilitating 
protein deficiency, depletion and wasting (William, 1989). The fact that the methanol extract of A. laxiflora leaf 
was able to restore protein and albumin levels in the diabetic rats (Group 4) confirms A. laxiflora is able to 
ameliorate the derangement in metabolism associated with diabetes mellitus.  
Urea and creatinine are markers of renal dysfunction (El-Demeradash et al., 2005). In the present study, 
urea and creatinine were significantly increased in the diabetic rats. In diabetes, amino acid breakdown in the 
liver and muscle tissues of diabetic animals results in an increased production of urea and creatinine, as observed 
in the diabetic animals (William, 1989). Furthermore, since its rate of production is constant, elevation of plasma 
creatinine is indicative of under-excretion, suggesting kidney impairment (Kumar and Clark, 2000). The 
reduction in urea and creatinine levels on administration of the extract suggests A. laxiflora may have reversed 
the impairment in the kidneys with proper glycaemic control in the diabetic rats.  
The activities of the aminotransferases in blood are useful indicators of liver damage/disease. The 
statistically significant increases in plasma activities of the liver marker enzymes aspartate aminotransferase, 
alanine aminotransferase and alkaline phosphatase in the diabetic rats suggest damage to the liver. Many 
researchers have reported increase in aminotransferase activities in the liver and serum (Shanmugasundaram et 
al., 1983). The gradual restoration back to normal values on administration of the extract suggests A. laxiflora 
was able to restore the architecture of the liver hitherto damaged.  
 
5. CONCLUSION 
The observations in this study have shown that the methanol extract of A. laxiflora leaf is able to ameliorate the 
biochemical defects indicative of diabetes mellitus. Since it had no significant effects on normal rats, its 
mechanism of action may be similar to that of biguanides (metformin) which rather than increase insulin 
secretion, reduce gluconeogenesis thus suppressing hepatic glucose output thereby producing 
antihyperglycaemic effect and not hypoglycaemic effect (Knowler et al., 2002).  
 
ACKNOWLEDGEMENT  
Special thanks to Dr. Aigbokan of the Department of Plant Biology and Biotechnology, University of Benin, 
Benin City, Nigeria for identifying and authenticating the plant used in the study.  
 
REFERENCES 
Adegoke, E.A., Akinsanya, A. and Naqui, S.H.S. (1968). Studies of Nigeria medicinal plants I. A preliminary 
survey of plant alkaloids. J. West Africa Sci. Assoc., 13: 13-33. 
Adewole, A.A. (1993). Personal communication with local traditional medical practitioners in Ibadan, Nigeria. J. 
Ethnopharmacol. 29: 207-211. 
Adeyemi, O., Makinwa, T.T. and Uadia, R.N. (2015). Ethanol Extracts of Roots of Anchomanes difformis ENGL 
Roots as an Antihyperglycaemic Agent in Diabetic Rats. Chemistry Journal 1(3): 68-73. 
Chase, P.H. and Glasgow, A.M. (1976). Juvenile Diabetes Mellitus and Serum Lipids and Lipoprotein Levels. 
America J. Dis. Child 130: 1113. 
Doumas, B.T., Watson, W.A. and Biggs, H.G. (1971). Clin. Chim. Acta. 31: 87. 
Duncan, D.B. (1955). Multiple range and multiple F test. Bionet 11:1-10. 
El-Demeradash, F.M., Yousef, M.L. and Abou El-Naga, N.L. (2005). Biochemical study and the hypoglycaemic 
effects of onion and garlic in alloxan-induced diabetic rats. Food Chem. Toxicol. 43: 57-63. 
Farombi, E.O., Ogundipe, O.O., Uhunwagho, E.S., Adeyanju, M.A. and Moody, S.O. (2003). Antioxidant 
properties of extracts from Alchornea laxiflora (Benth) Pax and Hoffman. Phytotherapy Res. 7: 713-716. 
Ingrid, F. and Matthias, F.M. (2006). Traditionally used plants in diabetes therapy-phytotherapeutics as 
inhibitors of α-amylase activity. Brazilian Journal of Pharmacognosy 16(1): 1-5. 
Knowler, N., Barrett-Connor, E., Fowler, S. et al. (2002). Reduction in the incidence of type 2 diabetes with life 
style intervention of metformin. N. Engl. J. Med. 346(6): 393-403. 
Kumar, P. and Clark, M. (2005). Diabetes mellitus and other disorders of metabolism. In: Clinical Medicine. 6th 
ed. Elsevier Saunders Spain pp. 1101-1134. 
Markx, J. (2002). Unraveling the causes of Diabetes. Science, 296: 686-689. 
Nimenibo-Uadia, R. and Osagie, A.U. (1999). Effect of an aqueous extract of Canavalia ensiformis (DC) seeds 
in normoglycaemic and alloxan-induced hyperglycaemic rats. Medical Science Research, 27: 397 – 399. 
Rother, K.I. (2007). Diabetes Treatment-Bridging the Divide. N. Engl. Med. J. 356(15): 1499-1501. 
Shanmugasundaram, K.R., Panneerselvam, C., Samudram, P. and Shanmugasundaram, E.R.B. (1983). Enzyme 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.8, No.8, 2018 
 
10 
changes and Glucose utilization in diabetic rabbits: the effect of Gymnema sylvestre, R. Br. Journal of 
Ethnopharmacol. 7: 205-234. 
Sharma, S.B., Nashir, A., Prabhu, K.M., Murtay, P.S. and Dev, G. (2003). Hypoglycemic and hypolipidemic 
effect of ethanolic extract of seeds of Eugenia jambolana in alloxan induced diabetic rabbits. J. 
Ethnopharmacol. 85: 201-206. 
Steel, R.G.O. and Torrie, J.H. (1960). Principles and Procedures of Statistics, McGraw Hill Book Company Inc. 
London, p.15. 
Tietz, N.W. (1995). Clinical Guide to Laboratory Tests. (3rd ed.). W.B. Saunders Company Philadelphia, PA. pp. 
518–519. 
Trinder, P. (1969). Determination of blood glucose using 4-aminophenazone as oxygen acceptor. J. Clin. Path. 
22: 246-248.  
UK Prospective Diabetes Study (UKPDS) Group (1998). Effect of intensive blood glucose control with 
metformin on complications in overweight patients with type 2 diabetes. Lancet, 352 (9131): 854-865. 
Weatherburn , M.W. (1967). Urea-berthelot method, colorimetric manual, Anal. Chem. 39: 971.  
WHO (1980). The WHO Expert Committee on Diabetes mellitus. Second Report. Technical Report Series 646, 
p.61: World Health Organization, Geneva. 
WHO (2003). Screening for type 2 diabetes: Report of a World Health Organization and International Diabetes 
Federation Meeting: Geneva: World Health Organization.  
William, F.G. (1989). Endocrine functions of the pancreas and regulation of carbohydrate metabolism In: 
Review of Medical Physiology 20th ed. Lange Medical Books/McGraw Hill, New York, pp. 324-338. 
